Literature DB >> 9882344

Coxsackievirus and adenovirus receptor amino-terminal immunoglobulin V-related domain binds adenovirus type 2 and fiber knob from adenovirus type 12.

P Freimuth1, K Springer, C Berard, J Hainfeld, M Bewley, J Flanagan.   

Abstract

The extracellular region of the coxsackievirus and adenovirus receptor (CAR) is predicted to consist of two immunoglobulin (Ig)-related structural domains. We expressed the isolated CAR amino-terminal domain (D1) and a CAR fragment containing both extracellular Ig domains (D1/D2) in Escherichia coli. Both D1 and D1/D2 formed complexes in vitro with the recombinant knob domain of adenovirus type 12 (Ad12) fiber, and D1 inhibited adenovirus type 2 (Ad2) infection of HeLa cells. These results indicate that the adenovirus-binding activity of CAR is localized in the amino-terminal IgV-related domain and confirm our earlier observation that Ad2 and Ad12 bind to the same cellular receptor. Preliminary crystallization studies suggest that complexes of Ad12 knob bound to D1 will be suitable for structure determination.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9882344      PMCID: PMC103963     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Unrelated animal viruses share receptors.

Authors:  K Lonberg-Holm; R L Crowell; L Philipson
Journal:  Nature       Date:  1976-02-26       Impact factor: 49.962

2.  The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.

Authors:  P J Maddon; A G Dalgleish; J S McDougal; P R Clapham; R A Weiss; R Axel
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

3.  Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection.

Authors:  J Zabner; P Freimuth; A Puga; A Fabrega; M J Welsh
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

4.  Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily.

Authors:  C L Mendelsohn; E Wimmer; V R Racaniello
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

5.  A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses.

Authors:  K H Hsu; K Lonberg-Holm; B Alstein; R L Crowell
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

Review 6.  Mass mapping with the scanning transmission electron microscope.

Authors:  J S Wall; J F Hainfeld
Journal:  Annu Rev Biophys Biophys Chem       Date:  1986

7.  A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses.

Authors:  D E Staunton; V J Merluzzi; R Rothlein; R Barton; S D Marlin; T A Springer
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

8.  The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand.

Authors:  J Bella; P R Kolatkar; C W Marlor; J M Greve; M G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

9.  The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses.

Authors:  J M Bergelson; A Krithivas; L Celi; G Droguett; M S Horwitz; T Wickham; R L Crowell; R W Finberg
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

10.  Virus-receptor interaction in an adenovirus system.

Authors:  L Philipson; K Lonberg-Holm; U Pettersson
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

View more
  41 in total

1.  Construction of a pseudoreceptor that mediates transduction by adenoviruses expressing a ligand in fiber or penton base.

Authors:  D A Einfeld; D E Brough; P W Roelvink; I Kovesdi; T J Wickham
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Adenovirus serotype 30 fiber does not mediate transduction via the coxsackie-adenovirus receptor.

Authors:  Lane K Law; Beverly L Davidson
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  Transgenic expression of the coxsackie/adenovirus receptor enables adenoviral-mediated gene delivery in naive T cells.

Authors:  Y Y Wan; R P Leon; R Marks; C M Cham; J Schaack; T F Gajewski; J DeGregori
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

4.  Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridge.

Authors:  Nikolay Korokhov; Galina Mikheeva; Alexander Krendelshchikov; Natalya Belousova; Vera Simonenko; Valentina Krendelshchikova; Alexander Pereboev; Alexander Kotov; Olga Kotova; Pierre L Triozzi; Wayne A Aldrich; Joanne T Douglas; Kin-Ming Lo; Papia T Banerjee; Stephen D Gillies; David T Curiel; Victor Krasnykh
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

Review 5.  Breaking into the epithelial apical-junctional complex--news from pathogen hackers.

Authors:  Roger Vogelmann; Manuel R Amieva; Stanley Falkow; W James Nelson
Journal:  Curr Opin Cell Biol       Date:  2004-02       Impact factor: 8.382

Review 6.  Adenovirus receptors.

Authors:  Yuanming Zhang; Jeffrey M Bergelson
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 7.  Protein aggregation and bioprocessing.

Authors:  Mary E M Cromwell; Eric Hilario; Fred Jacobson
Journal:  AAPS J       Date:  2006-09-15       Impact factor: 4.009

Review 8.  Synapses: sites of cell recognition, adhesion, and functional specification.

Authors:  Soichiro Yamada; W James Nelson
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

9.  The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells.

Authors:  M Kim; L A Sumerel; N Belousova; G R Lyons; D E Carey; V Krasnykh; J T Douglas
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

Review 10.  Adenovirus receptors and their implications in gene delivery.

Authors:  Anurag Sharma; Xiaoxin Li; Dinesh S Bangari; Suresh K Mittal
Journal:  Virus Res       Date:  2009-02-26       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.